Results 91 to 100 of about 9,874 (219)

Bordetella pertussis Strain Lacking Pertactin and Pertussis Toxin

Emerging Infectious Diseases, 2016
A Bordetella pertussis strain lacking 2 acellular vaccine immunogens, pertussis toxin and pertactin, was isolated from an unvaccinated infant in New York State in 2013.
Margaret M. Williams, Kathryn Sen, Michael R. Weigand, Tami H. Skoff, Victoria A. Cunningham, Tanya A. Halse, M. Lucia Tondella   +6 more
doaj   +1 more source

Randomised study of the possible adjuvant effect of BCG vaccine on the immunogenicity of diphtheria-tetanus-acellular pertussis vaccine in Senegalese infants

, 1999
Following a study in Senegal (1990-1995) in which the relative efficacy of a diphtheria-tetanus-acellular pertussis vaccine (DTaP) was compared with that of a diphtheria-tetanus-whole-cell pertussis vaccine in children given a simultaneous injection of ...
Préziosi, M.P., Yam, A., Hoffenbach, A., Chabirand, L., Wassilak, S., Salomon, H., Pinchinat, S., Trape, Jean-François, Simondon, François, Pines, E.   +9 more
core   +1 more source

Low tetanus-diphtheria-acellular pertussis (Tdap) vaccine coverage among healthcare workers in a quaternary university hospital in São Paulo, Brazil: need for continuous surveillance and implementation of active strategies

Brazilian Journal of Infectious Diseases, 2019
Introduction: Vaccination with tetanus-diphtheria-acellular pertussis (Tdap) has been recommended for healthcare workers (HCWs) by Brazilian Ministry of Health since November 2014. Objective: To describe the strategies implemented to improve Tdap uptake,
Bruno Azevedo Randi, Karina Takesaki Miyaji, Amanda Nazareth Lara, Karim Yaqub Ibrahim, Vanessa Infante, Camila Cristina Martines Rodrigues, Marta Heloísa Lopes, Ana Marli Christovam Sartori   +7 more
doaj   +1 more source

Randomized Trial on the Safety, Tolerability, and Immunogenicity of MenACWY-CRM, an Investigational Quadrivalent Meningococcal Glycoconjugate Vaccine, Administered Concomitantly with a Combined Tetanus, Reduced Diphtheria, and Acellular Pertussis Vaccine in Adolescents and Young Adults.

, 2010
This study evaluated the safety, tolerability, and immunogenicity of an investigational quadrivalent meningococcal conjugate vaccine, MenACWY-CRM, when administered concomitantly with a combined tetanus, reduced diphtheria, and acellular pertussis (Tdap)
GABUTTI, Giovanni, GASPARINI, ROBERTO, G. Bona, BONA, Gianni, Anemona A, Ceddia F., R. Gasparini, M. Conversano, Gabutti G, Gasparini R, PM Dull, F. Ceddia, A. Anemona, BONA G, Conversano M, Dull PM   +15 more
core   +1 more source

Avidity of pertussis toxin antibodies following vaccination with genetically versus chemically detoxified pertussis toxin-containing vaccines during pregnancy

Frontiers in Immunology
BackgroundBoth the quantity and quality of circulating anti-pertussis toxin antibodies are important for protection against severe pertussis. We compared the avidity of PT-IgG antibodies in pregnant women and their infants following vaccination during ...
Bahaa Abu-Raya, Bahaa Abu-Raya, Bahaa Abu-Raya, Giuseppe Del Giudice, Anita H. J. van den Biggelaar, Yuxiao Tang, Niranjan Bhat, Hong Thai Pham, Wassana Wijagkanalan   +8 more
doaj   +1 more source

PERTUSSIS IS COMING BACK? IMPROVEMENT OF FORGOTTEN CHILDHOOD INFECTION CONTROL

Педиатрическая фармакология, 2012
Infection that more than 60 years ago was recognized one of the leading childhood diseases that caused infant mortality, is returning. Of course, with the introduction of vaccination against pertussis in the national programs, we rarely meet severe ...
M. V. Fedoseenko, M. G. Galitskaya, M. I. Ivardava, A. G. Gaivoronskaya, N. A. Mayansky, V. V. Botvinieva, T. V. Rodionova   +6 more
doaj   +1 more source

Two consecutive randomized controlled pertussis booster trials in children initially vaccinated in infancy with an acellular vaccine: The first with a five-component Tdap vaccine to 5-year olds and the second with five- or monocomponent Tdap vaccines at age 14-15 years.

, 2015
Prior study children from a DTaP efficacy trial were recruited at ages 5 and 15 years to randomized booster trials addressing immunogenicity and reactogenicity; 475 preschool children received mixed or separate injections of a reduced antigen vaccine ...
Nilsson, L, Olin, P.,, Gustafsson, L.,, Netterlid, E.,, Nilsson, L., Gustafsson, L, Ljungman, M, Ljungman, M., Ljungman, M.,, Netterlid, E., Carlsson, R. M.,, Gothefors, L., Gothefors, L.,, Olin, P., Nilsson, Lennart,, Hallander, H. O., Gustafsson, L., Carlsson, R M, Gothefors, Leif,, Hallander, H O, Olin, P, Hallander, H. O.,, Nilsson, L.,, Carlsson, Rose-Marie,, Netterlid, Eva,, Netterlid, Eva, Lund University., Gothefors, L   +27 more
core   +1 more source

Impact of vaccination on epidemiology of diphtheria and pertussis

Vaccine Research, 2015
Whooping cough and diphtheria are vaccine preventable diseases. Diphtheria, due to Corynebacterium diphtheriae or Corynebactium ulcerans, two Gram positive bacteria, is a serious upper respiratory tract disease with high morbidity and mortality rates ...
N Guiso
doaj  

CD8(+) T cell adjuvant effects of Salmonella FliCd flagellin in live vaccine vectors or as purified protein

, 2010
Salmonella flagellin, the flagellum structural subunit, has received particular interest as a vaccine adjuvant conferring enhanced immunogenity to soluble proteins or peptides, both for activation of antibody and cellular immune responses. In the present
Rodrigues, Mauricio M. [UNIFESP], FERREIRA, Luis C. S., BOSCARDIN, Silvia B., RODRIGUES, Mauricio M., ALENCAR, Bruna C. G., SBROGIO-ALMEIDA, Maria E., Alencar, Bruna C. G. [UNIFESP], BARGIERI, Daniel Y., BRAGA, Catarina J. M., MASSIS, Liliana M., Bargieri, Daniel Y. [UNIFESP]   +10 more
core   +1 more source

Experience and challenges on influenza and pertussis vaccination in pregnant women

Human Vaccines & Immunotherapeutics, 2018
Young infants contribute to relatively high burden of vaccine-preventable diseases, including infections by influenza virus and Bordetella pertussis. Vaccination of pregnant women can enhance transplacental transfer of protective antibody to the fetus ...
Shabir A. Madhi, Marta C. Nunes
doaj   +1 more source